A detailed history of Jupiter Asset Management LTD transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Jupiter Asset Management LTD holds 78,578 shares of SRPT stock, worth $10 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
78,578
Holding current value
$10 Million
% of portfolio
0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$124.33 - $156.75 $9.77 Million - $12.3 Million
78,578 New
78,578 $9.81 Million
Q4 2023

Feb 09, 2024

BUY
$67.31 - $124.76 $1.15 Million - $2.14 Million
17,140 New
17,140 $1.65 Million
Q4 2022

Feb 10, 2023

BUY
$100.86 - $132.13 $2.49 Million - $3.26 Million
24,674 New
24,674 $3.2 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $11.2B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.